This extended gastric retention leads to prolonged satiety after meals and a more gradual release of nutrients into the bloodstream, helping reduce sharp post-meal glucose fluctuations
Even in aggressive scenarios for reduced consumption related to GLP-1 use, modest gains to life expectancy can more than offset the impact over time. Indeed, because obesity-related diseases cut years off average lifespans, treatment with GLP-1 drugs can add years (up to 14 years) to the lives of those who take them
Littorin B, Sundkvist G, Hagopian W et al (1999) Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment
Oral Drug Advancements Previously, a significant barrier to the widespread adoption of weight loss drugs has been the need for injections
Weight loss or metabolic shifts from GLP-1 drugs might affect your menstrual cycle
This deficiency can lead to difficulties in controlling hunger and maintaining healthy blood sugar levels, creating a cycle that makes weight loss challenging
